Clarification sought from Dishman Pharmaceuticals and Chemicals

17 Nov 2015 Evaluate

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals with reference to the news reported on moneycontrol on 17/11/2015 - ‘USFDA gives Warning Letter to Dishman due to Clovis issues’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.